medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2012, Number 1

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2012; 11 (1)

Are necessary the opioids and the adjuvants in the acute pain?

Pérez GY

Language: Spanish
References: 19
Page:
PDF size: 52.49 Kb.


ABSTRACT

Introduction: The therapeutic approach of acute pain must not to be and not to made from one only perspective and therefore the use of analgesic drugs like opioids and other types to achieve an effective relief of pain. Objective: To make a updating on the opioids and adjuvants in the treatment of chronic and acute pain. Development: Authors made an updating on this subject related to the role of opioids in the treatment of pain, as well as the advantages and disadvantages of other adjuvant drugs like the antidepressants and the anticonvulsants. It is emphasized on the advantages of exploration of the combination of opioids to improve its effectiveness. The tricyclic antidepressants are used in the neuropathic pain in particular and in the chronic pain in general, although the patient has not depression or anxiety. For these treatments lower doses are used and often produce more quick effects than other drugs. Besides, the new antiepileptic drugs have offered significant benefits due to its pharmacokinetic and pharmacodynamic characteristics of this pharmacological group. Today, there is a great knowledge on its mechanisms of action and its interactions increasing the use of the antiepileptic drugs in clinical entities no related to epilepsy by example, in the case of treatment of pain. Conclusions: The usefulness of opioids is confirmed as analgesic drugs associated with antidepressants, anticonvulsants and antiepileptics in the treatment of acute pain.


REFERENCES

  1. Ortega JL Neira F. Fisiología del dolor. Madrid: Ediciones Aran; 2001: 685-734.

  2. Bonica JJ. Postoperative pain. The management of pain. Filadelfia: Lea and Febiger; 1990: 461-80.

  3. Finkel D M. Desarrollo de Tolerancia a los Opioides ¿Mito o Realidad? Rev Arg Anest 2001; 59(1):54-66.

  4. Rowlinson JC. Advances in Acute Pain management. IARS 2000 Review Course Lectures. 65-72.

  5. Twycross R. G. Opioids. In: P. D. Wall and R. Melzack. Textbook of Pain. Churchill- Livingstone Ed. London- 3th Ed. 1994. pp. 954.

  6. Ripamonti C, De Conno F, Groff L. Equianalgesic dose/ratio between methadone and other opioids agonists in cancer pain: comparison of two clinical experiences. Ann Oncol 1998; 9: 79-83.

  7. Grond S, Meuser T, Pietruck C. Nociceptin and ORL1 receptor: pharmacology of a new opioid receptor. Anaesthesist 2002; 51(12): 996-1005.

  8. Stein C. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 2004; 108 (1-2): 67-75.

  9. De Leo JA, Tanga FY, Tawfik V L. Neuroinmune activation and neuroinflammation in chronic pain and opioid tolerance/hiperalgesia. Neuroscientist 2004; 10 (1): 40.52.

  10. Collins J V. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 2000; 20: 449-458.

  11. McQuay H. Review: tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia. Evid Based Med. 2002. pp.55-63.

  12. Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with .fibromyalgia with or without major depressive disorder. Pain 2005; 119: 5-15.

  13. Schneider C, Yale SH, Larson M. Principles of pain management. Clin Med Res 2003; 1:337-340.

  14. Grilo RM, Bertin P, Scotto di Fazano C. Opioid rotation in the treatment of joint pain. A review of 67 cases. Joint Bone Spine 2002; 69: 491-494.

  15. Perrot S, Javier RM, Marty M, Le Jeunne C, Laroche F. CEDR. Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies. Rheumatology (Oxford) 2008; 47:1117-23.

  16. Charles P. Taylor. Mechanisms of analgesia by gabapentin and pregabalin Calcium channel á2-ä [Cava2-d] ligands. Pain 2009;142:13-16

  17. Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC. Functional biology of the alpha 2 delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci 2007; 28: 220-8.

  18. Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex

  19. GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002; 159: 663-5.




2020     |     www.medigraphic.com